The VA's Fight Against Medical Marijuana Just Took a Hit

The state of New York just made a huge leap forward with medical marijuana - and the U.S. Department of Veteran Affairs, or VA, is not happy about it.

But it doesn't matter. The VA stands no chance against medical marijuana's insane trajectory.

Over the weekend, NY Gov. Andrew Cuomo signed new legislation that allows those in the state with post-traumatic stress disorder (PTSD) to use marijuana to treat symptoms. The bill has been touted as a boon for veterans in particular.

"Our veterans risked their lives in order to defend the ideals and principles that this nation was founded upon, and it is our duty to do everything we can to support them when they return home," said Cuomo, according to The Associated Press.

New York is the 28th state to legalize medical marijuana for PTSD, and this legislation is in direct opposition to the VA's negative stance on weed.

Never miss a single marijuana industry update again. To get real-time news sent directly to your inbox, sign up with one click here.

In fact, the VA would rather push highly addictive prescriptions, like opioids, on veterans struggling with PTSD than grant them access to medical marijuana.

Here's the thing...

The VA is on the wrong side of history - and everybody knows it.

Medical marijuana is saving lives all across the country. And with the help of states like New York, it's only getting bigger - and more profitable - for investors...

U.S. Veterans Want Legal Marijuana - and They Want It Now

Thousands of soldiers return from duty each year and head to VA clinics to seek help for physical pain, anxiety, depression, and insomnia, only to find themselves prescribed myriad opiates and other addictive medications.

In fact, VA prescriptions of four major potent opiates - hydrocodone, oxycodone, methadone, and morphine - more than tripled between 2001 and 2013, according to a report by the Center of Investigative Reporting.
The consequences of this mass increase in prescriptions are astonishing: Last year, the VA treated 66,000 ex-servicemen and women for opioid addiction.

"It is a travesty," said U.S. Rep. Dana Rohrabacher (R-CA) in a recent speech. "They are given opiates instead of maybe something they can derive from marijuana.... And our veterans end up killing themselves because now they are addicted to an opiate."

But now, veterans and legislators alike are increasing awareness of - and access to - medical marijuana...

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Special Report: Cannabis Is the Gold Rush of the 21st Century - 30 Stocks to Invest in Now. Details Here...

"We were hearing these compelling stories from veterans about how cannabis has made their lives better," said Joseph Plenzler, a spokesman for the American Legion, to LA Times. "That they were able to use it to get off a whole cocktail of drugs prescribed by VA doctors, that it is helping with night terrors, or giving them relief from chronic pain."

Video

Did Jeff Sessions Just Admit He Can't Stop Legal Marijuana?


The VA's resistance is just a speedbump in the road for medical marijuana. These objections can't stop the $6.7 billion industry.

Not when state after state is greenlighting the use of medical marijuana for more conditions than ever.

Right now, 29 states plus Washington, D.C., have legalized medical cannabis, with up to five more voting on it next fall. No matter how hard some may fight it, it's simply too late to stop legalization.

And thanks to the sweeping legalization, some marijuana stocks are seeing triple-digit gains of 224%... 378%... and even a whopping 751%.

We've made it easy for you to get started with a unique "pot investment" plan for the upcoming months.

In fact, Money Morning Director of Technology & Venture Capital Research - and our in-house pot stock expert - Michael A. Robinson has spent the last eight months and over $250,000 toward the most exhaustive analysis of the marijuana industry to date.

And he's vetted the next generations of weed stocks that are poised to make marijuana investors rich.

How to Profit from the Marijuana Windfall Today

Legal pot sales rose a stunning 34% in 2016, to $6.7 billion across North America, according to Arcview Market Research. What's more, that figure should surpass $8 billion by 2018 and reach $22.6 billion by 2021.

That works out to a 27.5% yearly growth rate.

And Arcview Market Research CEO Troy Dayton, with whom Michael recently met, says a compound growth rate of more than 20% a year will continue "for many years past 2021 as more states and countries legalize cannabis."

This means marijuana investing will be profitable for investors year after year - especially as more states, like New York, allow increased access to marijuana, both medical and recreational.

We've already seen how impressive the gains can be. This time last year, Michael released his "weed investor's bible," The Roadmap to Marijuana Millions. At the time, it was packed with 30 of his absolute favorite - and most profitable - plays in the still-booming legal cannabis sector.

Money Morning Members who received a copy of Roadmap saw 10 double-digit winners and eight triple-digit winners... 291% gains... 193.3%... 185.5%; one recommendation even saw peak gains of 1,588%.

Now, Michael's looking at four key events on the horizon that could lead to even more profits for investors.

  • California's upcoming legal marijuana declaration
  • Canada's total legalization of marijuana
  • Increase of cannabis-based treatments from top pharmaceutical companies
  • Major convergence of cryptocurrencies and legal cannabis

"These four watershed events in marijuana investing will happen over the next 365 days," Michael told readers on Sept. 14. "I'm sharing these predictions with everyone for the same reason I've shared some of my best weed investing recommendations: The profit potential is enormous."

Michael wants to make sure Money Morning Members know how to get the latest recommendations and research in his updated Roadmap to Marijuana Millions: Phase II.

Each copy of Roadmap: Phase II also comes with The Complete Angel Investor's Blueprint for Marijuana Startups - Michael's pre-IPO guidebook - so you can be the first to own privately held marijuana startups.

By investing today, you could see returns that yield more than 300% in coming months.

Don't miss out on this opportunity. Click here to learn how to get your copy now.

Follow Money Morning on Twitter @moneymorningFacebook, and LinkedIn.